Created in 2002 (United States), NULASTA own
142 sister brands
and 17478 competing brands.
NULASTA is owned by Amgen, listed on the stock exchange of New York
The sector of NULASTA is Drug Manufacturers.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.